These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 37175768)

  • 1. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection.
    Mantovani S; Oliviero B; Varchetta S; Renieri A; Mondelli MU
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Toll-like receptors in the pathogenesis of COVID-19.
    Khanmohammadi S; Rezaei N
    J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
    Manik M; Singh RK
    J Med Virol; 2022 Mar; 94(3):869-877. PubMed ID: 34672376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression Patterns of Toll-like Receptors in COVID-19 Patients.
    Lee N; Ko R; Lee SY
    Front Biosci (Landmark Ed); 2023 Nov; 28(11):307. PubMed ID: 38062845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.
    Choudhury A; Das NC; Patra R; Mukherjee S
    J Med Virol; 2021 Apr; 93(4):2476-2486. PubMed ID: 33404091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.
    Jung HE; Lee HK
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.
    Vakil MK; Mansoori Y; Al-Awsi GRL; Hosseinipour A; Ahsant S; Ahmadi S; Ekrahi M; Montaseri Z; Pezeshki B; Mohaghegh P; Sohrabpour M; Bahmanyar M; Daraei A; Dadkhah Jouybari T; Tavassoli A; Ghasemian A
    J Med Virol; 2022 Sep; 94(9):4088-4096. PubMed ID: 35538614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019.
    Dai J; Wang Y; Wang H; Gao Z; Wang Y; Fang M; Shi S; Zhang P; Wang H; Su Y; Yang M
    Front Microbiol; 2022; 13():948770. PubMed ID: 35832809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
    Sirén J; Pirhonen J; Julkunen I; Matikainen S
    J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.
    Manan A; Pirzada RH; Haseeb M; Choi S
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments.
    Liu ZM; Yang MH; Yu K; Lian ZX; Deng SL
    Front Pharmacol; 2022; 13():989664. PubMed ID: 36188605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2.
    Olímpio F; Andreata-Santos R; Rosa PC; Santos W; Oliveira C; Aimbire F
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1513-1528. PubMed ID: 36346611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
    Aboudounya MM; Heads RJ
    Mediators Inflamm; 2021; 2021():8874339. PubMed ID: 33505220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLRs govern neutrophil activity in aspergillosis.
    Bellocchio S; Moretti S; Perruccio K; Fallarino F; Bozza S; Montagnoli C; Mosci P; Lipford GB; Pitzurra L; Romani L
    J Immunol; 2004 Dec; 173(12):7406-15. PubMed ID: 15585866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections.
    Asaba CN; Ekabe CJ; Ayuk HS; Gwanyama BN; Bitazar R; Bukong TN
    J Inflamm Res; 2024; 17():5077-5091. PubMed ID: 39081874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.
    van der Sluis RM; Cham LB; Gris-Oliver A; Gammelgaard KR; Pedersen JG; Idorn M; Ahmadov U; Hernandez SS; Cémalovic E; Godsk SH; Thyrsted J; Gunst JD; Nielsen SD; Jørgensen JJ; Bjerg TW; Laustsen A; Reinert LS; Olagnier D; Bak RO; Kjolby M; Holm CK; Tolstrup M; Paludan SR; Kristensen LS; Søgaard OS; Jakobsen MR
    EMBO J; 2022 May; 41(10):e109622. PubMed ID: 35178710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.